Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
The top analyst upgrades, downgrades and other research calls from Tuesday include Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota and Twitter.
Published:
Last Updated:
This partnership should be fairly transformative for BeiGene, seeing as it can start making some actual money.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Bluebird, Celgene, Coach, 58.com, Gold Fields, Nike, Rite Aid, Vipshop and Waste Management.
Published:
Last Updated:
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
Agio Pharmaceuticals saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia.
Published:
Last Updated:
Friday’s top analyst upgrades, downgrades and initiations include Celgene, Kroger, Nike, Skyworks Solutions and Western Digital.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
24/7 Wall St. has screened the Credit Suisse Focus List to look for the stock for which Credit Suisse sees the most in implied total returns.
Published:
Last Updated:
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls on Friday include Celgene, Continental Resources, Hess, Renewable Energy, U.S. Bancorp and Zynga.
Published:
Last Updated:
24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their earnings on Thursday.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated: